Medicare Enrolled
Dr. Kumaran Sathyamoorthy, MD, MPH
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sathyamoorthy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sathyamoorthy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sathyamoorthy
Dr. Kumaran Sathyamoorthy is an urology physician in Houston, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Sathyamoorthy performed 6,676 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sathyamoorthy received a total of $6,668 from 57 pharmaceutical and/or device companies across 255 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sathyamoorthy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 16% volume in TX
$6,668 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,676
Medicare services
Top 16% in TX for urology physician
Not available
Unique patients (not deduplicated)
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,666 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,662 | $65 | $136 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,404 | $3 | $14 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
894 | $8 | $100 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
195 | $178 | $488 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
191 | $79 | $259 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
97 | $99 | $294 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 74 | $123 | $1,397 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
73 | $25 | $208 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
51 | $68 | $297 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
48 | $47 | $173 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $11 | $79 |
| Injection, garamycin, gentamicin, up to 80 mg | 42 | $2 | $32 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
39 | $172 | $435 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
32 | $105 | $305 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
29 | $46 | $195 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $145 | $368 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
22 | $71 | $1,123 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
18 | $224 | $770 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $103 | $251 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
16 | $104 | $1,344 |
| Ureteral stone crushing with endoscope A procedure to break up a stone in the ureter using an endoscope. The endoscope is inserted to locate and crush the stone. |
15 | $324 | $1,100 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
12 | $41 | $288 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $529 | $2,551 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
17.3% medium
82.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,668
Total received (2018-2024)
Avg $953/year across 7 years
Top 29% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
255
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,466
2023
$533
2022
$779
2021
$624
2020
$947
2019
$959
2018
$1,359
Payments by company (2024)
BIOTISSUE HOLDINGS INC.
$297
INTUITIVE SURGICAL, INC.
$187
Ferring Pharmaceuticals Inc.
$138
Endo USA, Inc.
$114
Astellas Pharma US Inc
$105
PROCEPT BioRobotics Corporation
$102
Axonics, Inc.
$94
Antares Pharma, Inc.
$59
ABBVIE INC.
$59
Sumitomo Pharma America, Inc.
$57
Boston Scientific Corporation
$49
PFIZER INC.
$38
Laborie Medical Technologies Corp.
$32
Ethicon US, LLC
$31
Myriad Genetic Laboratories, Inc.
$29
Abbott Laboratories
$22
Olympus America Inc.
$19
Endo Pharmaceuticals Inc.
$18
SRS Medical Systems, Inc.
$17
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,304
PFIZER INC.
$590
Endo Pharmaceuticals Inc.
$494
NeoTract Inc.
$328
BIOTISSUE HOLDINGS INC.
$297
Antares Pharma, Inc.
$295
Avanos Medical
$247
PROCEPT BioRobotics Corporation
$241
INTUITIVE SURGICAL, INC.
$187
BOSTON SCIENTIFIC CORPORATION
$174
NxThera, Inc.
$165
Ferring Pharmaceuticals Inc.
$160
Janssen Biotech, Inc.
$124
Endo USA, Inc.
$114
AbbVie Inc.
$111
Sumitomo Pharma America, Inc.
$111
Boston Scientific Corporation
$106
ABBVIE INC.
$98
Ethicon US, LLC
$98
Allergan, Inc.
$96
Axonics, Inc.
$94
Myovant Sciences Inc.
$81
KARL STORZ Lithotripsy-America, Inc.
$69
180 Medical, Inc.
$66
Myriad Genetic Laboratories, Inc.
$59
Allergan Inc.
$55
Olympus America Inc.
$54
TOLMAR Pharmaceuticals, Inc.
$52
AbbVie, Inc.
$52
Kowa Pharmaceuticals America, Inc.
$50
COLOPLAST CORP
$43
UROVANT SCIENCES INC
$42
Intuitive Surgical, Inc.
$39
Coloplast Corp
$38
Clarus Therapeutics Inc.
$36
Acerus Pharmaceuticals Corporation
$35
Janssen Pharmaceuticals, Inc
$32
Ambu Inc.
$32
Laborie Medical Technologies Corp.
$32
Medline Industries, Inc.
$30
Blue Earth Diagnostics Limited
$28
Metuchen Pharmaceuticals
$22
TherapeuticsMD, Inc.
$22
Telix Pharmaceuticals
$22
Abbott Laboratories
$22
Supernus Pharmaceuticals, Inc.
$22
UroGen Pharma, Inc.
$21
BioTissue Holdings, Inc.
$20
Aytu BioScience, Inc
$19
Cardinal Health 414 LLC
$19
Travere Therapeutics, Inc.
$18
Integra LifeSciences Corporation
$18
AMAG Pharmaceuticals, Inc.
$18
C. R. Bard, Inc. & Subsidiaries
$18
SRS Medical Systems, Inc.
$17
Mission Pharmacal Company
$16
Retrophin, Inc.
$13
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · ADSTILADRIN · ALTIS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Altis · Androgel · AquaBeam Robotic System · Axonics · Axumin · BIOFIX · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · CT3000 Pro Base Unit · Da Vinci Surgical System · ECHELON FLEX Stapler · ELIGARD · ERLEADA · Echelon Flex · Echelon; Endopath · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENTLECATH · General - Kidney Stone Disease · GentleCath · ILLUCCIX · IMVEXXY · INTRAROSA · JATENZO · JELMYTO · LOFRIC · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · ON-Q* PUMP AND ACCESSORIES · ORGOVYX · OTREXUP · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROCLAIM · PROLARIS · Prolaris · RESTORELLE · Rezum · Rezum Generator · SEGLENTIS · SUTENT · Seglentis · SpeediCath · Stendra · TLANDO · TOVIAZ · Thiola · UGN Laser Capital · Uribel · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
196
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST WILLOWBROOK HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sathyamoorthy is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sathyamoorthy experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Sathyamoorthy performed 1,666 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sathyamoorthy receive payments from pharmaceutical companies?
Yes. Dr. Sathyamoorthy received a total of $6,668 from 57 companies across 255 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sathyamoorthy's costs compare to other urology physicians in Houston?
Dr. Sathyamoorthy's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sathyamoorthy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology